Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
OTLK holding history
Outlook Therapeutics, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −3,807−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q4 2023 | 76,138 | $30.0K | <0.1% | −60,000−44.1% | Reduced | Holders |
| Q3 2023 | 136,138 | $30.1K | <0.1% | +115,570+561.9% | Added | Holders |
| Q2 2023 | 20,568 | $35.8K | <0.1% | +10,000+94.6% | Added | Holders |
| Q1 2023 | 10,568 | $11.5K | <0.1% | +10,568 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q3 2022 | 10,000 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,000 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,000 | $18.0K | <0.1% | +10,000 | New | Holders |